FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2899233732> ?p ?o ?g. }

• W2899233732 abstract "Apelin has been reported to be associated with multiple physiological processes in the cardiovascular system. The aim of the present study was to investigate the effects of Apelin‑13 administration on cardiac function, hyperglycemia, insulin resistance (IR), dyslipidemia, endothelial function, inflammation and glucose metabolism in type 2 diabetic Goto‑Kakizaki (GK) rats, and compare the protective effects of Apelin‑13 with metformin or atorvastatin. In the present study, type 2 diabetes was induced in male Goto‑Kakizaki (GK) rats fed with high‑fat diet (HFD). Simultaneously, the rats were treated with metformin (350 mg/kg/d, by gavage), atorvastatin (50 mg/kg/d, by gavage) or Apelin‑13 (200 µg/kg/d, intraperitoneal injection) once daily for 4 consecutive weeks. Hemodynamic parameters were examined by RM6240BD multi‑channel physiological signal monitoring. Fasting plasma glucose (FPG), fasting insulin (FINS), homeostasis model assessment for insulin resistance (HOMA‑IR), total cholesterol (TC), triglyceride (TG), high density lipoprotein‑cholesterol (HDL‑C), low density lipoprotein‑cholesterol (LDL‑C), endothelin‑1 (ET‑1), nitric oxide (NO), constitutive nitric oxide synthase (cNOS) activity, tumor necrosis factor‑α (TNF‑α), leptin and Apelin‑12 levels were measured. Western blotting was performed to determine the levels of Apelin‑12, glucose transporter 4 (GLUT4) and phosphorylated (p)‑5'adenosine monophosphate‑activated protein kinase (AMPK) α2. It was demonstrated that Apelin‑13 decreased heart rate, left ventricular end‑diastolic pressure, FPG, FINS, HOMA‑IR, TC, TG, LDL‑C, ET‑1, TNF‑α and leptin, whereas it increased the rise and fall of maximum rate of left ventricular pressure, HDL‑C, NO, cNOS activity and Apelin‑12 compared with the GK‑HFD group. In addition, GLUT4 and p‑AMPKα2 levels in myocardial tissues were elevated by administration of Apelin‑13. This protective effect of Apelin‑13 was comparable to that of metformin or atorvastatin. Overall, the present study demonstrated that administration ofApelin‑13 may be a promising therapeutic agent for the treatment of type 2 diabetes and metabolic syndrome." @default.
• W2899233732 created "2018-11-09" @default.
• W2899233732 creator A5078147293 @default.
• W2899233732 creator A5082080586 @default.
• W2899233732 creator A5087592842 @default.
• W2899233732 date "2018-10-29" @default.
• W2899233732 modified "2023-10-09" @default.
• W2899233732 title "Apelin‑13 ameliorates metabolic and cardiovascular disorders in a rat model of type 2 diabetes with a high‑fat diet" @default.
• W2899233732 cites W141271274 @default.
• W2899233732 cites W1538422979 @default.
• W2899233732 cites W1967918311 @default.
• W2899233732 cites W1972559234 @default.
• W2899233732 cites W1980930023 @default.
• W2899233732 cites W1996713062 @default.
• W2899233732 cites W2002120568 @default.
• W2899233732 cites W2005294551 @default.
• W2899233732 cites W2024124296 @default.
• W2899233732 cites W2030082538 @default.
• W2899233732 cites W2045730622 @default.
• W2899233732 cites W2050138576 @default.
• W2899233732 cites W2060660919 @default.
• W2899233732 cites W2069283761 @default.
• W2899233732 cites W2084746557 @default.
• W2899233732 cites W2088827845 @default.
• W2899233732 cites W2095554648 @default.
• W2899233732 cites W2095606893 @default.
• W2899233732 cites W2125700093 @default.
• W2899233732 cites W2140704600 @default.
• W2899233732 cites W2155061398 @default.
• W2899233732 cites W2189265867 @default.
• W2899233732 cites W2265429569 @default.
• W2899233732 cites W2290879873 @default.
• W2899233732 cites W2292914592 @default.
• W2899233732 cites W2326887525 @default.
• W2899233732 cites W2404216677 @default.
• W2899233732 cites W2414942129 @default.
• W2899233732 cites W2562617158 @default.
• W2899233732 cites W2586805554 @default.
• W2899233732 cites W2619848908 @default.
• W2899233732 cites W2621390856 @default.
• W2899233732 cites W2624949920 @default.
• W2899233732 cites W2729320554 @default.
• W2899233732 cites W2730113778 @default.
• W2899233732 cites W2731541918 @default.
• W2899233732 cites W2732603247 @default.
• W2899233732 cites W2733303138 @default.
• W2899233732 cites W2734424058 @default.
• W2899233732 cites W2747084217 @default.
• W2899233732 cites W2757591374 @default.
• W2899233732 cites W2760481920 @default.
• W2899233732 cites W4361808142 @default.
• W2899233732 cites W792142886 @default.
• W2899233732 cites W3152317553 @default.
• W2899233732 doi "https://doi.org/10.3892/mmr.2018.9607" @default.
• W2899233732 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30387843" @default.
• W2899233732 hasPublicationYear "2018" @default.
• W2899233732 type Work @default.
• W2899233732 sameAs 2899233732 @default.
• W2899233732 citedByCount "11" @default.
• W2899233732 countsByYear W28992337322020 @default.
• W2899233732 countsByYear W28992337322021 @default.
• W2899233732 countsByYear W28992337322022 @default.
• W2899233732 countsByYear W28992337322023 @default.
• W2899233732 crossrefType "journal-article" @default.
• W2899233732 hasAuthorship W2899233732A5078147293 @default.
• W2899233732 hasAuthorship W2899233732A5082080586 @default.
• W2899233732 hasAuthorship W2899233732A5087592842 @default.
• W2899233732 hasBestOaLocation W28992337321 @default.
• W2899233732 hasConcept C126322002 @default.
• W2899233732 hasConcept C134018914 @default.
• W2899233732 hasConcept C170493617 @default.
• W2899233732 hasConcept C2777180221 @default.
• W2899233732 hasConcept C2777391703 @default.
• W2899233732 hasConcept C2779306644 @default.
• W2899233732 hasConcept C2779546753 @default.
• W2899233732 hasConcept C2780323712 @default.
• W2899233732 hasConcept C2780613262 @default.
• W2899233732 hasConcept C511355011 @default.
• W2899233732 hasConcept C555293320 @default.
• W2899233732 hasConcept C71924100 @default.
• W2899233732 hasConceptScore W2899233732C126322002 @default.
• W2899233732 hasConceptScore W2899233732C134018914 @default.
• W2899233732 hasConceptScore W2899233732C170493617 @default.
• W2899233732 hasConceptScore W2899233732C2777180221 @default.
• W2899233732 hasConceptScore W2899233732C2777391703 @default.
• W2899233732 hasConceptScore W2899233732C2779306644 @default.
• W2899233732 hasConceptScore W2899233732C2779546753 @default.
• W2899233732 hasConceptScore W2899233732C2780323712 @default.
• W2899233732 hasConceptScore W2899233732C2780613262 @default.
• W2899233732 hasConceptScore W2899233732C511355011 @default.
• W2899233732 hasConceptScore W2899233732C555293320 @default.
• W2899233732 hasConceptScore W2899233732C71924100 @default.
• W2899233732 hasLocation W28992337321 @default.
• W2899233732 hasLocation W28992337322 @default.
• W2899233732 hasOpenAccess W2899233732 @default.
• W2899233732 hasPrimaryLocation W28992337321 @default.
• W2899233732 hasRelatedWork W1967954429 @default.
• W2899233732 hasRelatedWork W1985226700 @default.
• W2899233732 hasRelatedWork W1998534700 @default.
• W2899233732 hasRelatedWork W2020097924 @default.

• next